105 related articles for article (PubMed ID: 22911660)
1. Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions.
Sugito K; Kawashima H; Uekusa S; Yoshizawa S; Hoshi R; Furuya T; Kaneda H; Hosoda T; Masuko T; Ohashi K; Ikeda T; Koshinaga T; Fujiwara K; Igarashi J; Ghosh S; Held WA; Nagase H
Pediatr Blood Cancer; 2013 Mar; 60(3):383-9. PubMed ID: 22911660
[TBL] [Abstract][Full Text] [Related]
2. DNA hypomethylation at the ZNF206-exon 5 CpG island associated with neuronal differentiation in mice and development of neuroblastoma in humans.
Kawashima H; Sugito K; Yoshizawa S; Uekusa S; Furuya T; Ikeda T; Koshinaga T; Shinojima Y; Hasegawa R; Mishra R; Igarashi J; Kimura M; Wang X; Fujiwara K; Gosh S; Nagase H
Int J Oncol; 2012 Jan; 40(1):31-9. PubMed ID: 22011711
[TBL] [Abstract][Full Text] [Related]
3. GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma.
Gumy-Pause F; Pardo B; Khoshbeen-Boudal M; Ansari M; Gayet-Ageron A; Sappino AP; Attiyeh EF; Ozsahin H
Genes Chromosomes Cancer; 2012 Feb; 51(2):174-85. PubMed ID: 22045684
[TBL] [Abstract][Full Text] [Related]
4. Non-promoter DNA hypermethylation of Zygote Arrest 1 (ZAR1) in neuroblastomas.
Sugito K; Kawashima H; Yoshizawa S; Uekusa S; Hoshi R; Furuya T; Kaneda H; Hosoda T; Konuma N; Masuko T; Ohashi K; Ikeda T; Koshinaga T; Tomita R; Shinojima Y; Fujiwara K; Watanabe T; Held WA; Nagase H
J Pediatr Surg; 2013 Apr; 48(4):782-8. PubMed ID: 23583134
[TBL] [Abstract][Full Text] [Related]
5. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
[TBL] [Abstract][Full Text] [Related]
6. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of candidate tumor suppressor genes in neuroblastoma.
Hoebeeck J; Michels E; Pattyn F; Combaret V; Vermeulen J; Yigit N; Hoyoux C; Laureys G; De Paepe A; Speleman F; Vandesompele J
Cancer Lett; 2009 Jan; 273(2):336-46. PubMed ID: 18819746
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of multiple genes in neuroblastic tumours. relationship with MYCN amplification and allelic status at 1p.
Gonzalez-Gomez P; Bello MJ; Lomas J; Arjona D; Alonso ME; Amiñoso C; Lopez-Marin I; Anselmo NP; Sarasa JL; Gutierrez M; Casartelli C; Rey JA
Eur J Cancer; 2003 Jul; 39(10):1478-85. PubMed ID: 12826052
[TBL] [Abstract][Full Text] [Related]
9. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.
Ackermann S; Kocak H; Hero B; Ehemann V; Kahlert Y; Oberthuer A; Roels F; Theißen J; Odenthal M; Berthold F; Fischer M
BMC Cancer; 2014 Nov; 14():840. PubMed ID: 25406647
[TBL] [Abstract][Full Text] [Related]
10. Calreticulin expression in neuroblastoma--a novel independent prognostic factor.
Hsu WM; Hsieh FJ; Jeng YM; Kuo ML; Chen CN; Lai DM; Hsieh LJ; Wang BT; Tsao PN; Lee H; Lin MT; Lai HS; Chen WJ
Ann Oncol; 2005 Feb; 16(2):314-21. PubMed ID: 15668290
[TBL] [Abstract][Full Text] [Related]
11. Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon.
Uekusa S; Kawashima H; Sugito K; Yoshizawa S; Shinojima Y; Igarashi J; Ghosh S; Wang X; Fujiwara K; Ikeda T; Koshinaga T; Soma M; Nagase H
Int J Oncol; 2014 May; 44(5):1669-77. PubMed ID: 24626568
[TBL] [Abstract][Full Text] [Related]
12. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of human tissue-specific differences in methylation.
Igarashi J; Muroi S; Kawashima H; Wang X; Shinojima Y; Kitamura E; Oinuma T; Nemoto N; Song F; Ghosh S; Held WA; Nagase H
Biochem Biophys Res Commun; 2008 Nov; 376(4):658-64. PubMed ID: 18805397
[TBL] [Abstract][Full Text] [Related]
14. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
15. Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.
Decock A; Ongenaert M; Cannoodt R; Verniers K; De Wilde B; Laureys G; Van Roy N; Berbegall AP; Bienertova-Vasku J; Bown N; Clément N; Combaret V; Haber M; Hoyoux C; Murray J; Noguera R; Pierron G; Schleiermacher G; Schulte JH; Stallings RL; Tweddle DA; ; De Preter K; Speleman F; Vandesompele J
Oncotarget; 2016 Jan; 7(2):1960-72. PubMed ID: 26646589
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease.
Grau E; Martinez F; Orellana C; Canete A; Yañez Y; Oltra S; Noguera R; Hernandez M; Bermúdez JD; Castel V
Mol Carcinog; 2011 Mar; 50(3):153-62. PubMed ID: 21104989
[TBL] [Abstract][Full Text] [Related]
17. Tissue specific differentially methylated regions (TDMR): Changes in DNA methylation during development.
Song F; Mahmood S; Ghosh S; Liang P; Smiraglia DJ; Nagase H; Held WA
Genomics; 2009 Feb; 93(2):130-9. PubMed ID: 18952162
[TBL] [Abstract][Full Text] [Related]
18. Solute carrier family 16 member 5 downregulation and its methylation might serve as a prognostic indicator of prostate cancer.
Meng X; Yuan H; Li W; Xiong Z; Dong W; Xiao W; Zhang X
IUBMB Life; 2021 Nov; 73(11):1363-1377. PubMed ID: 34549875
[TBL] [Abstract][Full Text] [Related]
19. Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.
Brisse HJ; Blanc T; Schleiermacher G; Mosseri V; Philippe-Chomette P; Janoueix-Lerosey I; Pierron G; Lapouble E; Peuchmaur M; Fréneaux P; Galmiche L; Algret N; Peycelon M; Michon J; Delattre O; Sarnacki S
PLoS One; 2017; 12(9):e0185190. PubMed ID: 28945781
[TBL] [Abstract][Full Text] [Related]
20. Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.
Banelli B; Bonassi S; Casciano I; Mazzocco K; Di Vinci A; Scaruffi P; Brigati C; Allemanni G; Borzì L; Tonini GP; Romani M
Int J Cancer; 2010 Feb; 126(3):656-68. PubMed ID: 19626586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
